日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Staphylococcus haemolyticus Translation initiation factor IF-2 (infB), partial CSB-YP680102SBAH
CSB-EP680102SBAH
CSB-BP680102SBAH
CSB-MP680102SBAH
CSB-EP680102SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Ribosome-binding factor A (rbfA) CSB-YP680103SBAH
CSB-EP680103SBAH
CSB-BP680103SBAH
CSB-MP680103SBAH
CSB-EP680103SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus tRNA pseudouridine synthase B (truB) CSB-YP680104SBAH
CSB-EP680104SBAH
CSB-BP680104SBAH
CSB-MP680104SBAH
CSB-EP680104SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 30S ribosomal protein S15 (rpsO) CSB-YP680105SBAH
CSB-EP680105SBAH
CSB-BP680105SBAH
CSB-MP680105SBAH
CSB-EP680105SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP680106SBAH
CSB-EP680106SBAH
CSB-BP680106SBAH
CSB-MP680106SBAH
CSB-EP680106SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Ribonuclease J 2 (SH1638), partial CSB-YP680107SBAH
CSB-EP680107SBAH
CSB-BP680107SBAH
CSB-MP680107SBAH
CSB-EP680107SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Protein RecA (recA) CSB-YP680108SBAH
CSB-EP680108SBAH
CSB-BP680108SBAH
CSB-MP680108SBAH
CSB-EP680108SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat ADP-ribosylation factor GTPase-activating protein 3 (Arfgap3) CSB-YP680171RA
CSB-EP680171RA
CSB-BP680171RA
CSB-MP680171RA
CSB-EP680171RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Pre-mRNA-splicing regulator WTAP (wtap) CSB-YP680172XBE
CSB-EP680172XBE
CSB-BP680172XBE
CSB-MP680172XBE
CSB-EP680172XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein argonaute-4 (eif2c4), partial CSB-YP680173XBE
CSB-EP680173XBE
CSB-BP680173XBE
CSB-MP680173XBE
CSB-EP680173XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing) (Dak) CSB-YP680174RA
CSB-EP680174RA
CSB-BP680174RA
CSB-MP680174RA
CSB-EP680174RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Cyclin-dependent kinase 20 (Cdk20) CSB-YP680175RA
CSB-EP680175RA
CSB-BP680175RA
CSB-MP680175RA
CSB-EP680175RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Cleavage and polyadenylation specificity factor subunit 5 (Nudt21) CSB-YP680176RA
CSB-EP680176RA
CSB-BP680176RA
CSB-MP680176RA
CSB-EP680176RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Etoposide-induced protein 2.4 homolog (Ei24), partial CSB-YP680177RA1
CSB-EP680177RA1
CSB-BP680177RA1
CSB-MP680177RA1
CSB-EP680177RA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Gamma-glutamylaminecyclotransferase (A2ld1) CSB-YP680178RA
CSB-EP680178RA
CSB-BP680178RA
CSB-MP680178RA
CSB-EP680178RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Transmembrane protein 52B (TMEM52B), partial CSB-YP680179HU1
CSB-EP680179HU1
CSB-BP680179HU1
CSB-MP680179HU1
CSB-EP680179HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Cation transport regulator-like protein 2 (chac2) CSB-YP680180DIL
CSB-EP680180DIL
CSB-BP680180DIL
CSB-MP680180DIL
CSB-EP680180DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human TBC1 domain family member 10B (TBC1D10B), partial CSB-YP680181HU
CSB-EP680181HU
CSB-BP680181HU
CSB-MP680181HU
CSB-EP680181HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pinctada fucata Serine/threonine-protein kinase H1 homolog (PSKH1) CSB-YP680182EVV
CSB-EP680182EVV
CSB-BP680182EVV
CSB-MP680182EVV
CSB-EP680182EVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Protein unc-13 homolog A (Unc13a), partial CSB-YP680183MO
CSB-EP680183MO
CSB-BP680183MO
CSB-EP680183MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×